Aligos therapeutics to announce second quarter 2021 results august 5, 2021

South san francisco, calif., july 29, 2021 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it will report the company's second quarter 2021 financial results on thursday, august 5, 2021 after the close of u.s. financial markets.
ALGS Ratings Summary
ALGS Quant Ranking